Cargando…
Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis
OBJECTIVES: The objectives were 2-fold: (1) to describe the utilization patterns of new users of triptan therapy and (2) to measure the direct (pharmacy and medical) costs of migraine-related health care services in moderate-to-severe migraine patients treated with drug prophylaxis compared with mig...
Autores principales: | Etemad, Lida R., Yang, Winnie, Globe, Denise, Barlev, Arie, Johnson, Kathleen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438223/ https://www.ncbi.nlm.nih.gov/pubmed/15766320 http://dx.doi.org/10.18553/jmcp.2005.11.2.137 |
Ejemplares similares
-
Perinatal use of triptans and other drugs for migraine—A nationwide drug utilization study
por: Tauqeer, Fatima, et al.
Publicado: (2021) -
Stroke, Migraine and Triptans: From Bedside to Bench
por: Raschi, Emanuel, et al.
Publicado: (2016) -
Headaches related to triptans therapy in patients of migrainous vertigo
por: Prakash, Sanjay, et al.
Publicado: (2008) -
Efficacy of frovatriptan as compared to other triptans in migraine with aura
por: Evers, Stefan, et al.
Publicado: (2015) -
All triptans are not the same
por: Rapoport, Alan M., et al.
Publicado: (2001)